Cargando…
Chromatin as a Target for the DNA-Binding Anticancer Drugs
Chemotherapy has been a major approach to treat cancer. Both constituents of chromatin, chromosomal DNA and the associated chromosomal histone proteins are the molecular targets of the anticancer drugs. Small DNA binding ligands, which inhibit enzymatic processes with DNA substrate, are well known i...
Autores principales: | Majumder, Parijat, Pradhan, Suman K., Devi, Pukhrambam Grihanjali, Pal, Sudipta, Dasgupta, Dipak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121056/ https://www.ncbi.nlm.nih.gov/pubmed/17484128 http://dx.doi.org/10.1007/1-4020-5466-1_8 |
Ejemplares similares
-
Effect of DNA Groove Binder Distamycin A upon Chromatin Structure
por: Majumder, Parijat, et al.
Publicado: (2011) -
Minor Groove Binder Distamycin Remodels Chromatin but Inhibits Transcription
por: Majumder, Parijat, et al.
Publicado: (2013) -
The DNA intercalators ethidium bromide and propidium iodide also bind to core histones
por: Banerjee, Amrita, et al.
Publicado: (2014) -
Studies on the binding affinity of anticancer drug mitoxantrone to chromatin, DNA and histone proteins
por: Hajihassan, Zahra, et al.
Publicado: (2009) -
DNA-Binding Anticancer Drugs: One Target, Two Actions
por: Baguley, Bruce C., et al.
Publicado: (2021)